Sufentanil as Adjuvant of Balanced Anesthesia

• Status: Completed
• Trial end date: 2020-01-12
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study was to compare the efficacy and safety between sufentanil and remifentanil as an adjuvant of balanced general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kangbuk Samsung Hospital
• Treatments: Anesthetics; Remifentanil; Sufentanil

Criteria

Inclusion Criteria:

• Patients aged between 19 and 65 years

• Patients with American Society of Anesthesiologists physical status I or II

• Patients scheduled for elective laparoscopic cholecystectomy under balanced general anesthesia for benign cholecystic diseases

• Patients obtaining written informed consent

Exclusion Criteria:

• Patients with asthma or hypertension

• Patients with an inability to express their pain accurately

• Patients with an inability to understand the pain scale

• Patients with chronic abdominal pain or chronic pain syndrome

• Patients who required to convert to laparotomy from laparoscopic surgery

• Patients who required to receive incidental lower abdominal procedures owing to adhesion, injury, or other incidental findings at the lower abdominal cavity

• Patients with a history of drug or alcohol abuse

• Pregnant women